Ishaan Tewarie
InvestorVice President at EQT Life Sciences
Amsterdam, Netherlands
Writes $11M – $65M checks · typically $25M
Find your path to Ishaan
347 people in our graph share verified history with Ishaan — schools, employers, funds. One of them is your warm intro.
René KuijtenunlockedIshaan: together at Netherlands Academy of Engineering (2025–2026)
×9Ishaan: together at EQT Group
×2Ishaan: together at EQT Life Sciences
About
Ishaan Tewarie is a Vice President at EQT Group's Life Sciences business line, focusing on healthcare and life sciences investments. He brings experience in investing, company building, and board-level engagement with biotech and medtech companies, supported by an MD and research fellowship at Harvard Medical School. His background includes investment training and think tank participation.
Experience
- EQT GroupVice Presidentcurrent2024 — present
- EQT GroupInvestment Associate2022 — 2024
- Neuros Medical, Inc.Board Membercurrent2025 — present
- Minervax ApSBoard Observercurrent2025 — present
- Vico TherapeuticsBoard Observercurrent2025 — present
- NWO (Dutch Research Council)Selection Committee Membercurrent2024 — present
- Netherlands Academy of EngineeringPartner Council Membercurrent2025 — present
- De ZorgambassadeThink Tank member2025
- TEQ CapitalInvestment Consultant2021 — 2022
- Harvard Medical SchoolDoctoral Research Fellow2019 — 2021Boston, Massachusetts
- Pillar VCFellow2020 — 2021Boston, MA
- MIT Hacking MedicineTeam Member2019 — 2020Cambridge, Massachusetts
- ERBS - Erasmus Research & Business SupportThink Tank Member2018 — 2019Rotterdam Area, Netherlands
- Stichting MECOMCo-Founder and Previous Board Member2016 — 2018Utrecht Area, Netherlands
- Capita Selecta StudieondersteuningGeneral Manager2017 — 2018Rotterdam Area, Netherlands
- Capita Selecta StudieondersteuningRepetitor / Teacher (Medicine)2015 — 2018Rotterdam Area, Netherlands
- the jEURnalistPolitical Columnist2015 — 2017Rotterdam Area, Netherlands
Skills & more
Management1Analytical Skills1Machine LearningStrategic CommunicationsResearchPublic Speaking
Languages Dutch · English · German · Hindi
- LBO modeling training — EQT Group
- Healthcare Ventures — Massachusetts Institute of Technology
- Applied Biostatistics — Harvard Catalyst | The Harvard Clinical and Translational Science Center
- Medical Device Development — Harvard Catalyst | The Harvard Clinical and Translational Science Center
- Tropical Medicine Course — Erasmus MC
- EHBO/BLS — Erasmus MC
From Ishaan's professional profile.
Colleagues at EQT Life Sciences
Alex Darden
Partner and Head of EQT Infrastructure Advisory Team Americas & President of EQT Partners Inc at EQT Ventures
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Chris Stone
Investor at EPIC VENTURES
Christina Drews
Chief Operating Officer at EQT Life Sciences
Network1
Investors connected to Ishaan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Ishaan Tewarie?
- Ishaan Tewarie is a Vice President at EQT Group's Life Sciences business line, focusing on healthcare and life sciences investments. He brings experience in investing, company building, and board-level engagement with biotech and medtech companies, supported by an MD and research fellowship at Harvard Medical School. His background includes investment training and think tank participation.
- Where does Ishaan Tewarie work?
- Ishaan Tewarie is Vice President at EQT Life Sciences.
- What check size does Ishaan Tewarie write?
- Ishaan Tewarie typically writes checks of $11M – $65M.
- Where did Ishaan Tewarie go to school?
- Ishaan Tewarie studied at Harvard Medical School (Doctoral Research Fellowship); Erasmus University Rotterdam (Master of Science (MSc) / MD program, Medicine); Erasmus University Rotterdam (Bachelor of Science (BSc), Medicine).
Same school
Also attended Harvard Medical School245
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 239 more
Also attended Erasmus University Rotterdam262
Alessandro TavecchioPartner at P101 VenturesDick SietsesInvestment Partner Health at Capricorn Venture PartnersKonradInvestment Team at Hummingbird VenturesProf. Dr. Elbert DijkgraafBestuurslid at NoaberJohanneke van de Scheur-BaanBestuurslid at NoaberMaarten FischerHead of Programs at Noaber
+ 256 more
Shared employers
Also worked at Vico Therapeutics3
Also worked at NWO (Dutch Research Council)5
Luc StarmansPartner at Brightlands Venture PartnersFloris HamelInvestor at BOMMarie WeijlerPartner at TIIN CapitalLaura ThissenPrev. Managing Director at StartLife / Impact-driven strategist / Startup mentor & Advisor to investors at Grey Silo VenturesTheodoor RutgersInvestment Partner at Catalyze Capital
Also worked at Harvard Medical School274
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux CapitalZach CollinsPartner at Mission BiocapitalAlexi Nazem, MDGeneral Partner at AlleyCorp
+ 268 more
